Trexquant Investment LP - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 158 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 1.46 and the average weighting 0.0%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$304,946
-79.2%
16,448
-84.9%
0.01%
-80.0%
Q1 2023$1,464,918
+20.8%
109,078
+11.3%
0.04%
+17.6%
Q4 2022$1,212,272
-13.0%
98,001
-1.9%
0.03%
-30.6%
Q3 2022$1,393,000
+67.8%
99,852
+66.1%
0.05%
+32.4%
Q2 2022$830,000
+60.5%
60,121
+72.6%
0.04%
-9.8%
Q3 2021$517,000
-17.0%
34,839
+29.0%
0.04%
-28.1%
Q1 2021$623,000
-13.6%
27,004
+55.3%
0.06%
+23.9%
Q3 2020$721,000
+7.6%
17,387
+63.4%
0.05%
-6.1%
Q1 2020$670,000
+9.5%
10,640
+15.3%
0.05%
-7.5%
Q3 2019$612,000
-53.6%
9,227
-44.3%
0.05%
-55.5%
Q2 2019$1,319,000
-53.8%
16,576
-35.0%
0.12%
-41.4%
Q1 2019$2,853,000
+134.8%
25,509
+111.5%
0.20%
+167.1%
Q4 2018$1,215,000
-47.0%
12,059
-67.6%
0.08%
-52.5%
Q1 2018$2,291,000
+120.9%
37,238
+491.1%
0.16%
-31.0%
Q3 2016$1,037,000
-7.5%
6,300
-27.8%
0.23%
+77.1%
Q1 2016$1,121,000
-47.6%
8,729
-32.3%
0.13%
-28.8%
Q3 2015$2,139,000
+67.2%
12,900
+143.4%
0.18%
+27.8%
Q2 2015$1,279,000
-6.8%
5,300
-39.8%
0.14%
-40.7%
Q4 2014$1,372,0008,8000.24%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q1 2021
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 185,781$4,611,56512.16%
Samsara BioCapital, LLC 640,688$11,878,3563.64%
ALPINE ASSOCIATES MANAGEMENT INC. 2,203,295$40,849,0892.14%
Versor Investments LP 378,480$7,017,0191.42%
Magnetar Financial LLC 2,407,209$44,629,6551.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,077,893$38,524,1360.85%
Fort Baker Capital Management LP 430,600$7,983,3240.74%
EHP Funds Inc. 84,210$1,561,2530.73%
Terrapin Asset Management, LLC 30,000$556,2000.63%
AQR Arbitrage LLC 734,970$13,626,3440.61%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders